BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26839961)

  • 1. Cellular Retinoic Acid Binding Protein 2 Is Strikingly Downregulated in Human Esophageal Squamous Cell Carcinoma and Functions as a Tumor Suppressor.
    Yang Q; Wang R; Xiao W; Sun F; Yuan H; Pan Q
    PLoS One; 2016; 11(2):e0148381. PubMed ID: 26839961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of tumor-suppressive function of SOX6 in human esophageal squamous cell carcinoma.
    Qin YR; Tang H; Xie F; Liu H; Zhu Y; Ai J; Chen L; Li Y; Kwong DL; Fu L; Guan XY
    Clin Cancer Res; 2011 Jan; 17(1):46-55. PubMed ID: 21084391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Aza-2'-deoxycytidine induces retinoic acid receptor-beta(2) demethylation and growth inhibition in esophageal squamous carcinoma cells.
    Liu Z; Zhang L; Ding F; Li J; Guo M; Li W; Wang Y; Yu Z; Zhan Q; Wu M; Liu Z
    Cancer Lett; 2005 Dec; 230(2):271-83. PubMed ID: 16297713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation of genes linked to retinoid signaling in squamous cell carcinoma of the esophagus: DNA methylation of CRBP1 and TIG1 is associated with tumor stage.
    Mizuiri H; Yoshida K; Toge T; Oue N; Aung PP; Noguchi T; Yasui W
    Cancer Sci; 2005 Sep; 96(9):571-7. PubMed ID: 16128742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel tumor-suppressor gene PLC delta 1 at 3p22 in esophageal squamous cell carcinoma.
    Fu L; Qin YR; Xie D; Hu L; Kwong DL; Srivastava G; Tsao SW; Guan XY
    Cancer Res; 2007 Nov; 67(22):10720-6. PubMed ID: 18006814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kruppel-like factor 2 suppresses mammary carcinoma growth by regulating retinoic acid signaling.
    Zhang W; Levi L; Banerjee P; Jain M; Noy N
    Oncotarget; 2015 Nov; 6(34):35830-42. PubMed ID: 26416422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RRIG1 mediates effects of retinoic acid receptor beta2 on tumor cell growth and gene expression through binding to and inhibition of RhoA.
    Liang ZD; Lippman SM; Wu TT; Lotan R; Xu XC
    Cancer Res; 2006 Jul; 66(14):7111-8. PubMed ID: 16849557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma.
    Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY
    Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β1 induces epigenetic silence of TIP30 to promote tumor metastasis in esophageal carcinoma.
    Bu F; Liu X; Li J; Chen S; Tong X; Ma C; Mao H; Pan F; Li X; Chen B; Xu L; Li E; Kou G; Han J; Guo S; Zhao J; Guo Y
    Oncotarget; 2015 Feb; 6(4):2120-33. PubMed ID: 25544767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma.
    Kano M; Seki N; Kikkawa N; Fujimura L; Hoshino I; Akutsu Y; Chiyomaru T; Enokida H; Nakagawa M; Matsubara H
    Int J Cancer; 2010 Dec; 127(12):2804-14. PubMed ID: 21351259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the novel tumor suppressor DIRAS1 predicts poor prognosis in esophageal squamous cell carcinoma.
    Zhu YH; Fu L; Chen L; Qin YR; Liu H; Xie F; Zeng T; Dong SS; Li J; Li Y; Dai Y; Xie D; Guan XY
    Cancer Res; 2013 Apr; 73(7):2298-309. PubMed ID: 23436800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of PI3K in esophageal squamous cell carcinoma].
    Zhang Y; Liu YP; Du K; Wang H; Wang XL
    Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):594-8. PubMed ID: 22325219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
    Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
    J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma.
    Tong M; Chan KW; Bao JY; Wong KY; Chen JN; Kwan PS; Tang KH; Fu L; Qin YR; Lok S; Guan XY; Ma S
    Cancer Res; 2012 Nov; 72(22):6024-35. PubMed ID: 22991305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of TSLC1 in progression of esophageal squamous cell carcinoma.
    Ito T; Shimada Y; Hashimoto Y; Kaganoi J; Kan T; Watanabe G; Murakami Y; Imamura M
    Cancer Res; 2003 Oct; 63(19):6320-6. PubMed ID: 14559819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of MED23 promoted the tumorigenecity of esophageal squamous cell carcinoma.
    Shi J; Han Q; Zhao H; Zhong C; Yao F
    Mol Carcinog; 2014 Oct; 53(10):833-40. PubMed ID: 23625751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of LGI1 promotes tumor metastasis in esophageal squamous cell carcinoma.
    Zhu YH; Liu H; Zhang LY; Zeng T; Song Y; Qin YR; Li L; Liu L; Li J; Zhang B; Guan XY
    Carcinogenesis; 2014 May; 35(5):1154-61. PubMed ID: 24510112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The deregulation of arachidonic acid metabolism-related genes in human esophageal squamous cell carcinoma.
    Zhi H; Zhang J; Hu G; Lu J; Wang X; Zhou C; Wu M; Liu Z
    Int J Cancer; 2003 Sep; 106(3):327-33. PubMed ID: 12845669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ECM protein LTBP-2 is a suppressor of esophageal squamous cell carcinoma tumor formation but higher tumor expression associates with poor patient outcome.
    Chan SH; Yee Ko JM; Chan KW; Chan YP; Tao Q; Hyytiainen M; Keski-Oja J; Law S; Srivastava G; Tang J; Tsao SW; Chen H; Stanbridge EJ; Lung ML
    Int J Cancer; 2011 Aug; 129(3):565-73. PubMed ID: 20878956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.